Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Current Taxes (2020 - 2023)

Cytek Biosciences' Current Taxes history spans 4 years, with the latest figure at $246000.0 for Q2 2023.

  • For Q2 2023, Current Taxes changed N/A year-over-year to $246000.0; the TTM value through Jun 2023 reached $246000.0, changed N/A, while the annual FY2022 figure was $1.4 million, 42.61% down from the prior year.
  • Current Taxes reached $246000.0 in Q2 2023 per CTKB's latest filing, roughly flat from $246000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $2.7 million in Q1 2022 to a low of $158000.0 in Q2 2021.
  • Average Current Taxes over 4 years is $1.0 million, with a median of $480500.0 recorded in 2020.
  • Peak YoY movement for Current Taxes: surged 429.06% in 2021, then tumbled 91.03% in 2023.
  • A 4-year view of Current Taxes shows it stood at $468000.0 in 2020, then soared by 429.06% to $2.5 million in 2021, then tumbled by 42.61% to $1.4 million in 2022, then crashed by 82.69% to $246000.0 in 2023.
  • Per Business Quant, the three most recent readings for CTKB's Current Taxes are $246000.0 (Q2 2023), $246000.0 (Q1 2023), and $1.4 million (Q4 2022).